By Mark Harrington Winter 2007 Mark Harrington, executive director of the Treatment Action Group, in an opinion published in the Cape Times argues that we are living in a time of potentially great scientific accomplishments ... but we are missing…
Experimental Treatments and Preventive Therapies for HIV, Hepatitis C, and Tuberculosis: By Mark Harrington, Bob Huff, and Richard Jefferys. Reviewed by Tracy Swan, Javid Syed, Claire Wingfield, and Jen Curry.
Tuberculosis Research & Development: A Critical Analysis By Cindra Feuer October 2006 - This report is the product of an effort by the Treatment Action Group (TAG) to ascertain the major funders of tuberculosis (TB) research and development (R&D) in…
What’s in the Pipeline: New HIV Drugs, Vaccines, Microbicides, HCV and TB Therapies in Clinical Trials By Rob Camp, Richard Jefferys, Tracy Swan & Javid Syed Edited by Bob Huff August 2006 From the Forword: Twenty-five years into the global…
Published 2006 This publication is cosponsored by the Open Society Institute, a private operating and grantmaking foundation whose aim is to shape public policy in order to promote democratic governance, human rights, and economic, legal, and social reform, and the…
Statement of Individuals from Communities Affected by Tuberculosis (TB) 36th IUATLD World Congress on Lung Health 23 October 2005 Paris, France We are individuals from communities affected by the worldwide pandemic of tuberculosis (TB). We have seen the unnecessary suffering…
What’s in the Pipeline: New HIV Drugs, Vaccines, Microbicides, HCV and TB Treatments in Clinical Trials By Rob Camp, Richard Jefferys, Tracy Swan & Javid Syed Edited by Mark Harrington & Bob Huff July 2005 From the Introduction: This overview…